What You Should Know:
- Cleerly, the company creating a new standard of care for heart disease, announced that it has closed a Series C financing round of $192M
- This new funding, led by led by funds and accounts advised by T. Rowe Price Associates, Inc. and T. Rowe Price Investment Management, Inc., and Fidelity Management and Research Company, brings the total raised by the fast-growing health care company to $248M, which includes its Series B round in 2021
AI-enabled Approach
Read More
Heart Disease | Transforming Heart Disease through Medical Technology for Patients
Caption Health Receives CE Mark for AI Ultrasound Tech
What You Should Know:
- Caption Health, the leader in using artificial intelligence (AI) and services to improve heart ultrasound access, today announced that it has received a CE Mark for its Caption AI™ technology platform.
- This certification represents the first step in making Caption Health’s industry-leading technology platform available outside the US, and highlights the company’s strong clinical and regulatory track record as it uses AI and ultrasound to deliver better cardiac
Read More
FDA Clears Eko’s Heart Disease Detection AI for Adults and Pediatrics
What You Should Know:
- Today, Eko, a digital health company advancing heart and lung disease detection, has announced the FDA has issued clearance for its Eko Murmur Analysis Software (EMAS), the first and only machine learning algorithm to screen for valvular heart disease (VHD).
- The next generation of Eko’s murmur detection capabilities grants Eko the first and only smart stethoscope on the market that can identify and
Read More
How AI Can Accurately Detect Diabetes Through Retinal Images
Recent advancements in AI have demonstrated that AI can accurately detect diabetes through the analysis of retinal images that retina experts would consider healthy. To better understand this achievement, it is worth taking a step back to understand the context and magnitude of the achievement.
Diabetes is a chronic health condition that affects the body’s ability to metabolize glucose, resulting in high levels of sugars in the bloodstream. Over time, elevated blood sugar levels can
Read More
Outdated Pain Models & The Rise of New Science on Chronic Pain
More than 50 million adults in the United States – more than 20% – suffer from chronic pain, and more than 19.6 million adults have pain that interferes with their lives more days than not. The estimated cost of chronic pain is $635 billion – more than heart disease and cancer combined – due to the number of days missed from work, treatment costs, and other factors. Chronic pain is the leading cause of disability, but the current pain treatment system isn’t working. This is because it hasn’t
Read More
Geisinger & Tempus Create AI Model to Identify Structural Heart Disease
What You Should Know:
- Tempus, an $8B precision medicine company, announced a collaborative study with Geisinger focusing on artificial intelligence (AI) model that can accurately identify patients at increased risk of undiagnosed structural heart disease (SHD). The study addresses a critical diagnostic gap – SHD is a progressive disease that affects the valves, walls, chambers, and muscles of the heart, and causes debilitating symptoms or death, yet many patients with the disease go
Read More
Hello Heart Raises $70M to Expand Heart Health Solutions
What You Should Know:
- Hello Heart, the only digital therapeutics company focused exclusively on heart disease, announced a $70M Series D funding round led by Stripes to support its rapid growth in the employer market
- The funding round will specifically support the increase in employer market demand for Hello Heart’s technology as a focus on heart health sharpens. The company has experienced massive growth in the employer market, doubling the number of clients in the last three
Read More
4C Medical Technologies Nabs $35M, Appoints New President and CEO
What You Should Know:
- 4C Medical Technologies, a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease raises $35.4M in Series C funding was led by MicroPort CardioFlow Medtech Corporation (HKEX:2160).
- The Company's AltaValve® would be the first MR treatment with atrial-only fixation that is designed to minimize known issues associated with current TMVR technologies,
Read More
Eko Unveils Newly Designed Heart Disease Detection App
What You Should Know:
- Eko, a digital health company advancing heart and lung disease detection, today announced the launch of its newly-redesigned Eko App, which will transform patient interactions into an opportunity to screen for cardiovascular disease. Heart disease is the leading cause of death in the U.S., and there has not been an efficient and affordable solution to screen for heart disease at the physical exam until now.
- Eko has transformed the traditional stethoscope into an
Read More
Recora Raises $20M for Virtual Cardiac Recovery Platform
What You Should Know:
- Recora today emerged from stealth to announce $20M in Series A funding led by SignalFire with participation from Valor Equity Partners and existing investor Pear VC.
- In addition, the company while also unveiled its Cardiac Recovery Program for health systems, medical groups and health plans.
Redefining the Future of Heart Health
Recora is redesigning heart health, beginning with cardiac recovery. Cardiac rehabilitation is indicated
Read More
